Valuation dashboard for PAVmed Inc. (PAVM) with P/E N/A, P/B 0.70, EV/EBITDA -2.65 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay.
Analysis Summary
Trailing-twelve-month margins: gross margin -254.5%, operating margin -238.4%, net margin -107.9%.
At the current price of $3.92, PAVM has negative trailing earnings (P/E not meaningful) and an ROE of -33.51%. Market capitalisation stands at $25M.
Balance sheet quality for PAVM: current ratio of 0.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.70 |
| EV / EBITDA | -2.65 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-19.01 |
| vs Current Price | -584.9% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| PAVM | PAVmed Inc. | $25M | 0.70 | -33.5% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 29.27 | 4.55 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $66.5B | 48.91 | 5.86 | 11.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $3.92 |
| Market Cap | $25M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -33.51% |
| Return on Invested Capital | -72.77% |
| Return on Assets | -30.06% |
| Gross Margin | -254.46% |
| Operating Margin | -23842.86% |
| Net Margin | -10794.64% |
Related companies: ADVB · APVO · BMRA · BNR · DHAI · HSCS · IINN
Explore sector: Healthcare · Medical - Devices
More sections of PAVM: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks